Hsbc Holdings PLC purchased a new position in shares of National HealthCare Corporation (NYSEAMERICAN:NHC – Free Report) in the second quarter, Holdings Channel.com reports. The firm purchased 7,809 shares of the company’s stock, valued at approximately $1,639,000.
Several other large investors have also made changes to their positions in NHC. BlackRock Inc. bought a new stake in National HealthCare in the second quarter worth $417,602,000. Morgan Stanley Institutional Investment Advisors LLC bought a new stake in shares of National HealthCare during the 2nd quarter worth about $217,391,000. First Trust Advisors LP increased its holdings in shares of National HealthCare by 556.4% during the 3rd quarter. First Trust Advisors LP now owns 207,483 shares of the company’s stock valued at $25,211,000 after acquiring an additional 175,873 shares during the last quarter. Bank of New York Mellon Corp bought a new position in shares of National HealthCare in the 2nd quarter valued at approximately $25,854,000. Finally, Arrowstreet Capital Limited Partnership raised its stake in shares of National HealthCare by 407.2% in the 1st quarter. Arrowstreet Capital Limited Partnership now owns 75,257 shares of the company’s stock valued at $12,019,000 after acquiring an additional 60,420 shares in the last quarter. Institutional investors own 56.44% of the company’s stock.
National HealthCare Stock Performance
NHC opened at $222.70 on Monday. The business has a 50 day moving average of $219.36 and a 200-day moving average of $190.08. The stock has a market capitalization of $3.49 billion, a price-to-earnings ratio of 25.05 and a beta of 0.61. National HealthCare Corporation has a 1-year low of $111.24 and a 1-year high of $239.29.
National HealthCare Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 30th. Stockholders of record on Wednesday, September 30th will be issued a dividend of $0.67 per share. The ex-dividend date is Wednesday, September 30th. This represents a $2.68 annualized dividend and a dividend yield of 1.2%. National HealthCare’s payout ratio is presently 61.89%.
Insider Activity
In related news, CEO Stephen Fowler Flatt sold 1,500 shares of the stock in a transaction dated Wednesday, August 19th. The shares were sold at an average price of $237.08, for a total value of $355,620.00. Following the completion of the sale, the chief executive officer owned 65,487 shares in the company, valued at approximately $15,525,657.96. This trade represents a 2.24% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director David R. Gifford sold 1,779 shares of National HealthCare stock in a transaction dated Tuesday, August 25th. The stock was sold at an average price of $225.42, for a total value of $401,022.18. Following the sale, the director directly owned 1,030 shares in the company, valued at approximately $232,182.60. This trade represents a 63.33% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders own 13.92% of the company’s stock.
Wall Street Analysts Forecast Growth
NHC has been the subject of a number of recent analyst reports. Robert W. Baird raised National HealthCare to a “strong-buy” rating in a research report on Monday, May 18th. Royal Bank Of Canada raised shares of National HealthCare to a “hold” rating in a research report on Monday, May 18th. The Goldman Sachs Group upgraded shares of National HealthCare to a “strong-buy” rating in a research note on Monday, May 18th. Finally, BMO Capital Markets upgraded shares of National HealthCare to a “hold” rating in a research note on Monday, May 18th. Two investment analysts have rated the stock with a Strong Buy rating and two have issued a Hold rating to the company. According to MarketBeat, the stock has an average rating of “Buy”.
View Our Latest Stock Analysis on NHC
About National HealthCare
National HealthCare Corporation (NYSE American: NHC) is a healthcare services company specializing in long-term care and post-acute rehabilitation. The company operates skilled nursing facilities, assisted living communities and outpatient therapy clinics. Through its subsidiary, National HealthCare Partners, NHC provides contract rehabilitation services, pharmacy management and clinical consulting to a broad network of senior living and healthcare providers.
Headquartered in Murfreesboro, Tennessee, National HealthCare Corporation has built a regional footprint across the southeastern and south-central United States.
Recommended Stories
- Five stocks we like better than National HealthCare
- Strike a Balance Between Growth and Stability With These 3 Names Ready to Rally
- Rubrik’s AI Security Bet Could Power the Next Leg Higher
- Apple’s Foldable iPhone Could Be a Catalyst, But Not a Cure-All
- Snowflake Is Up Nearly 50% in 2026—What Are Short Sellers Betting Against?
Want to see what other hedge funds are holding NHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for National HealthCare Corporation (NYSEAMERICAN:NHC – Free Report).
Receive News & Ratings for National HealthCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National HealthCare and related companies with MarketBeat.com's FREE daily email newsletter.
